Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics - PubMed (original) (raw)
. 2006 Nov;7(11):3019-29.
doi: 10.1021/bm060504a.
Affiliations
- PMID: 17096527
- DOI: 10.1021/bm060504a
Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics
Simone C Rizzi et al. Biomacromolecules. 2006 Nov.
Abstract
We present here the biological performance in supporting tissue regeneration of hybrid hydrogels consisting of genetically engineered protein polymers that carry specific features of the natural extracellular matrix, cross-linked with reactive poly(ethylene glycol) (PEG). Specifically, the protein polymers contain the cell adhesion motif RGD, which mediates integrin receptor binding, and degradation sites for plasmin and matrix-metalloproteinases, both being proteases implicated in natural matrix remodeling. Biochemical assays as well as in vitro cell culture experiments confirmed the ability of these protein-PEG hydrogels to promote specific cellular adhesion and to exhibit degradability by the target enzymes. Cell culture experiments demonstrated that proteolytic sensitivity and suitable mechanical properties were critical for three-dimensional cell migration inside these synthetic matrixes. In vivo, protein-PEG matrixes were tested as a carrier of bone morphogenetic protein (rhBMP-2) to heal critical-sized defects in a rat calvarial defect model. The results underscore the importance of fine-tuning material properties of provisional therapeutic matrixes to induce cellular responses conducive to tissue repair. In particular, a lack of rhBMP or insufficient degradability of the protein-PEG matrix prevented healing of bone defects or remodeling and replacement of the artificial matrix. This work confirms the feasibility of attaining desired biological responses in vivo by engineering material properties through the design of single components at the molecular level. The combination of polymer science and recombinant DNA technology emerges as a powerful tool for the development of novel biomaterials.
Similar articles
- Protein-polymer conjugates for forming photopolymerizable biomimetic hydrogels for tissue engineering.
Gonen-Wadmany M, Oss-Ronen L, Seliktar D. Gonen-Wadmany M, et al. Biomaterials. 2007 Sep;28(26):3876-86. doi: 10.1016/j.biomaterials.2007.05.005. Epub 2007 May 18. Biomaterials. 2007. PMID: 17576008 - Synthetic extracellular matrices for in situ tissue engineering.
Pratt AB, Weber FE, Schmoekel HG, Müller R, Hubbell JA. Pratt AB, et al. Biotechnol Bioeng. 2004 Apr 5;86(1):27-36. doi: 10.1002/bit.10897. Biotechnol Bioeng. 2004. PMID: 15007838 - Customized PEG-derived copolymers for tissue-engineering applications.
Tessmar JK, Göpferich AM. Tessmar JK, et al. Macromol Biosci. 2007 Jan 5;7(1):23-39. doi: 10.1002/mabi.200600096. Macromol Biosci. 2007. PMID: 17195277 Review. - Synthetic biodegradable polymers as drug delivery systems for bone morphogenetic proteins.
Saito N, Murakami N, Takahashi J, Horiuchi H, Ota H, Kato H, Okada T, Nozaki K, Takaoka K. Saito N, et al. Adv Drug Deliv Rev. 2005 May 25;57(7):1037-48. doi: 10.1016/j.addr.2004.12.016. Epub 2005 Apr 15. Adv Drug Deliv Rev. 2005. PMID: 15876402 Review.
Cited by
- Enhanced bone regeneration in rat calvarial defects through BMP2 release from engineered poly(ethylene glycol) hydrogels.
Vallmajo-Martin Q, Millan C, Müller R, Weber FE, Ehrbar M, Ghayor C. Vallmajo-Martin Q, et al. Sci Rep. 2024 Feb 28;14(1):4916. doi: 10.1038/s41598-024-55411-z. Sci Rep. 2024. PMID: 38418564 Free PMC article. - Cell responses to the mechanochemical microenvironment--implications for regenerative medicine and drug delivery.
Rehfeldt F, Engler AJ, Eckhardt A, Ahmed F, Discher DE. Rehfeldt F, et al. Adv Drug Deliv Rev. 2007 Nov 10;59(13):1329-39. doi: 10.1016/j.addr.2007.08.007. Epub 2007 Aug 14. Adv Drug Deliv Rev. 2007. PMID: 17900747 Free PMC article. Review. - Biomaterial strategies for alleviation of myocardial infarction.
Venugopal JR, Prabhakaran MP, Mukherjee S, Ravichandran R, Dan K, Ramakrishna S. Venugopal JR, et al. J R Soc Interface. 2012 Jan 7;9(66):1-19. doi: 10.1098/rsif.2011.0301. Epub 2011 Sep 7. J R Soc Interface. 2012. PMID: 21900319 Free PMC article. Review. - The combination of stem cells and tissue engineering: an advanced strategy for blood vessels regeneration and vascular disease treatment.
Wang Y, Yin P, Bian GL, Huang HY, Shen H, Yang JJ, Yang ZY, Shen ZY. Wang Y, et al. Stem Cell Res Ther. 2017 Sep 15;8(1):194. doi: 10.1186/s13287-017-0642-y. Stem Cell Res Ther. 2017. PMID: 28915929 Free PMC article. Review. - Maleimide cross-linked bioactive PEG hydrogel exhibits improved reaction kinetics and cross-linking for cell encapsulation and in situ delivery.
Phelps EA, Enemchukwu NO, Fiore VF, Sy JC, Murthy N, Sulchek TA, Barker TH, García AJ. Phelps EA, et al. Adv Mater. 2012 Jan 3;24(1):64-70, 2. doi: 10.1002/adma.201103574. Epub 2011 Dec 16. Adv Mater. 2012. PMID: 22174081 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources